Ozempic Breath Is on the Rise—and So Is This Unlikely Winner
Summary
Hershey’s CEO told stockholders that GLP-1 side effects are creating a ‘strong demand for gum.’
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.